SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-20-000035
Filing Date
2020-05-13
Accepted
2020-05-13 16:54:57
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx10-q2020x03.htm 10-Q 967811
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit311.htm EX-31.1 9956
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit312.htm EX-31.2 9925
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit321.htm EX-32.1 7292
5 CERTIFICATION OF CFO PUSRUANT TO SARBANES-OXLEY ACT OF 2002 exhibit322.htm EX-32.2 7414
  Complete submission text file 0001610618-20-000035.txt   4408163

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20200331.xml EX-101.INS 646709
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20200331.xsd EX-101.SCH 43463
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20200331_cal.xml EX-101.CAL 51427
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20200331_def.xml EX-101.DEF 206649
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20200331_lab.xml EX-101.LAB 536435
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20200331_pre.xml EX-101.PRE 317001
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 20873907
SIC: 2836 Biological Products, (No Diagnostic Substances)